CIK: 1431759 - Address: C/o Acura Pharmaceuticals, Inc., 616 N. North Court, Suite 120, Palatine, IL 60067
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret1115-143110-54-1
P%wins1000100100100067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/20/23 12:08
11/20/23
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsJones Robert BILOP,CEOM.d00.000407644D
1/5/23 16:09
1/3/23
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsJones Robert BILOP,CEOM.d00.000509604D
8/5/22 16:17
8/3/22
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsJones Robert BILOP,CEOM.d00.0006413554D
1/6/21 16:11
1/4/21
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsJones Robert BILOP,CEOM.d00.0006415490D
1/6/20 16:39
1/2/20
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsJones Robert BILOP,CEOM.d00.000143426D
12/15/17 16:21
12/14/17
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsJones Robert BILDOP,CEOP400.10000400999%413D
8/17/11 07:22
8/15/11
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsJones Robert BILOP,CEOP103.23032195D-4426-3-28-1734165-143110-54

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact